Fitness coach shares ‘why young Malaysians are losing their kidneys’; some as young as 40
Rising cases of kidney problems are being reported among young adults in Malaysia, with lifestyle factors, poor diet,…
Reverse kidney damage: A breakthrough treatment that may transform kidney treatment |
Kidney disease has long been considered a progressive and irreversible condition, where treatment focuses only on slowing decline…
MannKind Announces U.S. FDA Accepts for Review its Supplemental New Drug Application (sNDA) of FUROSCIX ReadyFlow™ Autoinjector for the Treatment of Edema in Adults with Chronic Heart Failure or Chronic Kidney Disease
MannKind If approved, ReadyFlow Autoinjector would deliver an IV-equivalent diuretic dose (subcutaneous furosemide injection 80 mg/ml) in under…
Genetic risk scores fail to predict survival after diagnosis
New research across seven global biobanks shows that the DNA driving disease onset does not determine survival; instead,…
Health Canada approves Ozempic® to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease
Ozempic® is the first-and-only medication indicated for both the once-weekly treatment of adult patients with type 2 diabetes…
Unicycive Provides Update on New Drug Application for Oxylanthanum Carbonate to Treat Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis
Unicycive Therapeutics, Inc. – The U.S. Food and Drug Administration (FDA) identified deficiencies at a third-party manufacturing vendor…
Addressing Gaps in Employment Among Patients With Kidney Disease
Photo Credit: iStock.com/Goran13 Employment among patients with kidney disease remains low even after dialysis or a transplant, with…